Connect with us

Technology

Medirex Systems Inc. joins the Vector Institute’s FastLane program to accelerate AI-fueled growth

Published

2 years ago

on

TORONTO, Dec. 4, 2024 /CNW/ – Medirex Systems Inc., a leader in healthcare technology solutions, is thrilled to announce its participation in the Vector Institute’s FastLane program. Joining FastLane demonstrates Medirex’s ongoing commitment to artificial intelligence (AI) innovation to enhance patient engagement and optimize healthcare systems across Canada.

Through the program, Medirex aims to explore AI’s potential to transform healthcare delivery, mainly through its mySPOT platform, which leverages AI to simplify medical reports and streamline patient-provider communication. Medirex will engage in mentorship, gain access to machine learning resources, and collaborate with industry-thought leaders to develop responsible AI solutions that empower patients and improve healthcare outcomes.

Introduced in December 2021, the Vector Institute’s FastLane program supports Canadian small-to-medium-sized enterprises (SMEs) in accelerating their AI capabilities. Through Vector’s FastLane program, Medirex can access world-class AI expertise. This will support the company as it advances its mySPOT platform by integrating AI to enhance patient comprehension, improve real-time data analysis, and ensure patients actively participate in their healthcare journey. Joining FastLane will further Medirex’s goals of improving patient outcomes and driving operational efficiency within healthcare systems.

By building AI resources and fostering innovation, the Vector Institute is empowering SMEs like Medirex to harness machine learning’s transformational potential. Vector’s community of problem-solvers, experts, and leaders drives the responsible application, adoption, and commercialization of AI, fostering economic growth across Canada.

“We are thrilled to be part of Vector’s FastLane Program, which aligns perfectly with our mission to revolutionize healthcare through AI-powered innovation,” shares Mark Caskenette, Managing Director, Medirex Systems Inc. “Vector’s support through FastLane opens new doors for us to access cutting-edge AI expertise and advance our mySPOT platform, ensuring we continue to enhance the healthcare experience for patients and providers alike.”

“Vector’s FastLane program is designed to drive safe AI innovation and foster AI advancement for small and medium-sized enterprises,” said Craig Stewart, Executive Director of Applied AI Programs Vector Institute. “Medirex’s commitment to leveraging AI responsibly in health care aligns well with our mission. We’re excited to welcome the Medirex team to the FastLane.”

About Medirex Systems Inc.

Medirex Systems Inc. is a Canadian-owned healthcare technology company specializing in patient identification and digital engagement solutions. For over 50 years, Medirex has connected over 10 million patients annually to health information systems through advanced patient ID wristbands. It is now evolving into the digital space with mySPOT, a platform designed to empower patients by giving them control of their healthcare journey. Medirex aims to improve patient outcomes, reduce readmissions, and foster more personalized care through innovative AI solutions.

About Vector Institute

The Vector Institute, cofounded by Nobel laureate Geoffrey Hinton,  is an independent, not-for-profit corporation dedicated to advancing artificial intelligence, excelling in machine learning and deep learning. Our vision is to drive excellence and leadership in Canada’s knowledge, creation, and use of AI to foster economic growth and improve the lives of Canadians. The Vector Institute is funded by the Province of Ontario, the Government of Canada through the CIFAR Pan-Canadian AI Strategy, and industry sponsors across Canada.

Media Contact
Mark Caskenette, Managing Director
Medirex Systems Inc.
Email: m.caskenette@medirex.com
Website: medirex.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/medirex-systems-inc-joins-the-vector-institutes-fastlane-program-to-accelerate-ai-fueled-growth-302322942.html

SOURCE Medirex Systems Inc.

Related Topics:
Continue Reading

Technology

MiniTool ShadowMaker 5.0 Introduces Cloud Sync for Google Drive and OneDrive

Published

38 minutes ago

on

October 23, 2026

By

VANCOUVER, BC, Oct. 22, 2026 /PRNewswire/ — MiniTool® Software Limited has announced the release of MiniTool ShadowMaker 5.0, the latest version of its Windows backup and file sync software. The update introduces a new Cloud Sync feature for Google Drive and OneDrive, along with enhancements to the registration and purchase experience, interface refinements, and compatibility fixes.

New Features and Improvements in MiniTool ShadowMaker 5.0

1. Cloud Sync to Google Drive and OneDrive

MiniTool ShadowMaker 5.0 introduces Cloud Sync, allowing users to synchronize files and folders from a Windows computer to Google Drive or OneDrive. Users can choose the files and folders they want to sync and select their preferred cloud storage service as the destination.

The new feature supports one-way synchronization from a local Windows PC to cloud storage, providing an additional way to save copies of important files outside of your computer. Together with MiniTool ShadowMaker’s existing local file sync function, Cloud Sync expands the available destinations for file sync.

2. Streamlined License & Plan Management

The latest update introduces an enhanced register interface that remains easily accessible even after activation. Registered users can now effortlessly review their current plan, explore upgrade options, or update their license key anytime for a smoother user experience.

These refinements are intended to improve usability when users manage their software registration and licensing.

3. Interface Refinements and Compatibility Fixes

MiniTool ShadowMaker 5.0 includes interface improvements and fixes for certain display issues. One notable fix addresses a blurry display issue that could occur on some systems equipped with AMD GPUs.

These changes focus on resolving specific issues and improving the user experience on affected systems.

4. Additional Improvements

Beyond Cloud Sync and the changes outlined above, MiniTool ShadowMaker 5.0 includes additional interface and functionality refinements. Together, these updates further improve the software’s usability while expanding its file synchronization options.

With support for Google Drive and OneDrive, MiniTool ShadowMaker 5.0 provides Windows users with another approach to manage file copies across local and cloud storage. Users who want to synchronize files to cloud storage can download the Free Edition and explore the new capabilities.

About MiniTool ShadowMaker

MiniTool ShadowMaker is a Windows backup and file sync solution designed to help users protect their operating systems and important data. It supports backing up Windows systems, disks, partitions, files, and folders to local drives, external hard drives, shared folders, and other supported locations. Users can select specific items to back up according to their needs.

For users who need to migrate data to another drive, MiniTool ShadowMaker offers a disk cloning feature. The software also supports restoring backed-up data and creating bootable media for system recovery.

By combining backup, file synchronization, disk cloning, and restore capabilities, MiniTool ShadowMaker offers Windows users a set of tools for data protection and system recovery.

About MiniTool® Software Limited

MiniTool Software Limited is a professional software company that develops computer applications. It provides software for partition management, data recovery, data backup and sync, video editing, multimedia conversion, and screen recording for home and business users. The company is committed to developing innovative, reliable, and easy-to-use software that simplifies everyday digital tasks.

View original content to download multimedia:https://www.prnewswire.com/news-releases/minitool-shadowmaker-5-0-introduces-cloud-sync-for-google-drive-and-onedrive-302916663.html

SOURCE MiniTool® Software Limited

Continue Reading

Technology

Rocket Companies to Announce Third Quarter 2026 Results on October 29, 2026

Published

2 hours ago

on

October 22, 2026

By

DETROIT, Oct. 22, 2026 /PRNewswire/ — Rocket Companies, Inc. (NYSE: RKT) (“Rocket Companies” or “the Company”), the Detroit-based homeownership platform, today announced that the Company will issue its third quarter 2026 earnings on October 29, 2026. Leadership will host a conference call to discuss results at 4:30 p.m. ET on that date. A press release detailing the Company’s results will be issued prior to the call.

A live webcast of the event will be available on the “Events & Presentations” section of the Company’s Investor Relations website at ir.rocketcompanies.com. A replay of the webcast will be available on the Investor Relations website following the event.

About Rocket Companies

Founded in 1985, Rocket Companies (NYSE: RKT) is a Detroit-based homeownership platform including mortgage, real estate and personal finance businesses: Rocket Mortgage, Redfin, Rocket Close, Rocket Money and Rocket Loans.

With insights from more than 160 million calls with clients each year, more than 30 petabytes of data and a mission to Help Everyone Home, Rocket Companies is well positioned to be the destination for AI-fueled homeownership.

For more information, please visit the Company’s Corporate website or Investor Relations website.

View original content to download multimedia:https://www.prnewswire.com/news-releases/rocket-companies-to-announce-third-quarter-2026-results-on-october-29-2026-302917496.html

SOURCE Rocket Companies, Inc.

Continue Reading

Technology

Lunai Bioworks Announces Receipt of Nasdaq Determination and Intention to Voluntarily Delist and Deregister

Published

2 hours ago

on

October 22, 2026

By

SACRAMENTO, Calif., Oct. 22, 2026 /PRNewswire/ — Lunai Bioworks Inc. (Nasdaq: LNAI) (the “Company”) announced that on October 21, 2026, it received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company no longer complies with Nasdaq Listing Rule 5550(b)(1), which requires minimum stockholders’ equity of $2,500,000. The Company reported a stockholders’ deficit of $(9,024,946) in its Annual Report on Form 10-K for the fiscal year ended June 30, 2026, and does not meet the alternative market value of listed securities or net income standards. Because the Company is subject to a mandatory Hearings Panel Monitor under Nasdaq Listing Rule 5815(d)(4)(B), Nasdaq staff determined to delist the Company’s securities. Trading in the Company’s common stock on Nasdaq is expected to be suspended at the opening of business on October 30, 2026.

The Company will not request a hearing. Rather than contest the staff determination, the Company’s Board of Directors approved on October 22, 2026 the voluntary withdrawal of the Company’s common stock from listing on Nasdaq under Rule 12d2-2(c) under the Securities Exchange Act of 1934, as amended. The Board took this action because of the staff determination and the Company’s financial condition, and concluded that the cost of continued listing and SEC reporting is not justified.

The Company notified Nasdaq of its intention on October 22, 2026. The Company intends to file a Form 25 with the Securities and Exchange Commission (the “SEC”) on or about November 2, 2026, and expects the delisting to become effective on or about November 12, 2026. The Company then intends to file a Form 15 to suspend its SEC reporting obligations, to the extent it is eligible to do so. The Company’s SEC reporting obligations will continue unless and until they are terminated or suspended in accordance with the SEC’s rules.

The Company does not intend to arrange for quotation of its common stock on any over-the-counter market and cannot assure that any trading market for its common stock will exist after trading on Nasdaq is suspended.

Forward-Looking Statements
This press release contains forward-looking statements, including statements regarding the expected suspension of trading, the expected timing of the Form 25 and Form 15 filings, and the expected timing of delisting and deregistration. Actual results may differ materially due to risks and uncertainties, including Nasdaq and SEC procedures and the Company’s financial condition. The Company undertakes no obligation to update these statements, except as required by law.

View original content to download multimedia:https://www.prnewswire.com/news-releases/lunai-bioworks-announces-receipt-of-nasdaq-determination-and-intention-to-voluntarily-delist-and-deregister-302917510.html

SOURCE Lunai Bioworks Inc.

Continue Reading

Trending